S&P Futures

7,446.25

+44.25

+0.60%

Dow Futures

51,748.00

+363.00

+0.71%

Nasdaq Futures

27,244.50

+159.25

+0.59%

Russell 2000 Futures

2,783.00

+22.50

+0.82%

10-Yr Bond

4.8590

+0.0220

+0.45%

VIX

25.64

-2.54

-9.01%

Gold

4,129.50

+54.60

+1.34%

Bitcoin USD

74,950.39

-855.90

-1.13%

Crude Oil Dec 26

91.21

+0.38

+0.42%

US Private Equity

10,772.76

+11.83

+0.11%

NasdaqGM - Nasdaq Real Time Price USD

JATT II Acquisition Corp. (JATT)

10.34 0.00 (0.00%)

At close: November 5 at 4:00:00 PM EST

Loading Chart for JATT

Chart Range Bar

Interval:

In partnership with ChartIQ

Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases

Talawar Therapeutics to debut on Nasdaq with $285m as Dupixent challenger

JATT III Acquisition Corp Announces Closing of $69,000,000 Initial Public Offering

JATT III Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering

JATT II Acquisition Corp Announces Closing of $60,000,000 Initial Public Offering

Mobilize your Website

View Site in Mobile | Classic

Share by:

U.S. markets closed